← All sarcoma trials
Recruiting nowAges 18 Years to 39 Years

Early Ageing During Therapy in AYA Cancer Patients

Sponsor: University Medical Center Groningen · NCT05062707 on ClinicalTrials.gov ↗

Conditions studied

CancerLeukemiaHodgkin LymphomaTesticular CancerOsteosarcomaEwing SarcomaBreast CancerCervical Cancer

What it tests

  • Blood samplingprocedure

Where it's running1 site

1 international site
  • University Medical Center Groningen

    Groningen, Netherlands 9713 GZ

    Recruiting now
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Aged 18-39 years at cancer diagnosis
* Having a histologically and/or cytologically confirmed cancer diagnosis, including leukemia, (non-)Hodgkin lymphoma, testicular cancer, osteosarcoma, Ewing sarcoma, breast cancer, and cervical cancer.
* Scheduled to start systemic therapy with curative intent. Allowed treatments (concurrent or sequential) are: surgery, radiotherapy, chemotherapy, antibodies.

Exclusion Criteria:

* patients who are not able to understand the patient information letter and informed consent form
* patients who will be treated with immune checkpoint inhibitors or targeted therapy with inhibitors of angiogenesis
* patients who have been treated with systemic therapy or radiotherapy for a previous malignancy (exceptions: in situ carcinoma of the cervix or uterus and adequately treated basal and squamous cell carcinoma of the skin).

Updated 2025-05-13 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.